Smell recovery in patients with COVID-19: an experience with nebulized nasal treatment.

Varricchio, A; La Mantia, I; Brunese, F P; Ciprandi, G

Varricchio, A; La Mantia, I; Brunese, F P; Ciprandi, G.

Varricchio A; UOSD Video-Endoscopia delle VAS, P.O. San Gennaro - ASL Napoli 1-centro, Naples, Italy.
La Mantia I; ENT Department, University of Catania, Catania, Italy.
Brunese FP; Primary Care Paediatrics, ASL Caserta, Italy.
Ciprandi G; Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy.

J Biol Regul Homeost Agents ; 35(2): 683-686, 2021.

Article in English | MEDLINE | ID: covidwho-1138994

Subject(s)

COVID-19; Smell; Administration, Intranasal; Anosmia; Humans; SARS-CoV-2

Keywords

COVID-19; anosmia; cacosmia; hyaluronic acid; hypertonic saline; hyposmia; nebulization; xylitol

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Smell / COVID-19 Limits: Humans Language: English Journal: J Biol Regul Homeost Agents Journal subject: Biology / Biochemistry Year: 2021 Document Type: Article Affiliation country: 21-28-L

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google